Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T21:33:04.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and the funding notice banner and the previous revision (v3.4.1) were removed.
    Difference
    0.7%
    Check dated 2026-02-12T02:06:16.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Additions include a general site status notice about government funding and the current revision tag (v3.4.1). Deletion removes the previous revision tag (v3.4.0).
    Difference
    0.7%
    Check dated 2026-02-04T12:34:41.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI-related updates include showing the glossary, color-coded highlights for changes, and revision labels (v3.4.0) while the changes modify 'No FEAR Act' data text and versioning notes, affecting display rather than core study content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T11:09:46.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added and the previous revision v3.3.3 was removed in the study record history, reflecting internal version updates rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-01-14T03:30:11.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a new revision entry: Revision: v3.3.3. Removed HHS Vulnerability Disclosure and the older Revision: v3.3.2 from the page.
    Difference
    0.2%
    Check dated 2025-12-23T20:22:24.000Z thumbnail image

Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.